30,773 Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Bought by Wolverine Asset Management LLC

Key Points

• Wolverine Asset Management LLC has made a new investment in Acadia Healthcare Company, purchasing 30,773 shares valued at approximately $933,000.
• Acadia Healthcare's recent earnings report showed an earnings per share of $0.83, exceeding analysts' expectations of $0.71 with revenue of $869.23 million.
• Equity research analysts have set a target price around $44.75 for Acadia Healthcare, with a consensus rating of "Moderate Buy" among multiple ratings changes.

Wolverine Asset Management LLC bought a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 30,773 shares of the company's stock, valued at approximately $933,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of ACHC. Quadrant Capital Group LLC raised its position in Acadia Healthcare by 287.1% in the 4th quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock worth $50,000 after purchasing an additional 933 shares during the period. UMB Bank n.a. increased its holdings in Acadia Healthcare by 149.5% during the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after buying an additional 755 shares during the period. State of Wyoming purchased a new position in Acadia Healthcare in the fourth quarter worth $56,000. Covestor Ltd grew its holdings in shares of Acadia Healthcare by 27.2% during the fourth quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after buying an additional 310 shares during the last quarter. Finally, Aquatic Capital Management LLC purchased a new stake in shares of Acadia Healthcare during the fourth quarter valued at $97,000.

Analyst Ratings Changes

Several research firms have commented on ACHC. KeyCorp lowered their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Barclays cut their price objective on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a report on Thursday, August 7th. UBS Group cut their price target on shares of Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating for the company in a report on Thursday, August 7th. Guggenheim cut their target price on Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a research note on Thursday, August 7th. Finally, Stephens raised Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Five research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Acadia Healthcare has an average rating of "Moderate Buy" and an average price target of $44.75.

Acadia Healthcare Stock Up 6.6%

ACHC stock traded up $1.26 during midday trading on Tuesday, hitting $20.33. The company's stock had a trading volume of 2,898,844 shares, compared to its average volume of 2,153,748. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. Acadia Healthcare Company, Inc. has a 52-week low of $17.13 and a 52-week high of $82.40. The firm has a market capitalization of $1.88 billion, a P/E ratio of 13.46, a PEG ratio of 3.71 and a beta of 0.88. The firm has a 50-day simple moving average of $22.08 and a 200-day simple moving average of $27.42.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The company had revenue of $869.23 million during the quarter, compared to analysts' expectations of $839.59 million. During the same quarter last year, the company posted $0.91 EPS. The firm's revenue was up 9.2% compared to the same quarter last year. As a group, equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.